|
SEMA4D expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.042610E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.050600E-01 |
| Normal-vs-Stage2 |
9.458600E-01 |
| Normal-vs-Stage3 |
9.900000E-01 |
| Normal-vs-Stage4 |
1.510770E-01 |
| Stage1-vs-Stage2 |
2.663600E-01 |
| Stage1-vs-Stage3 |
2.100200E-01 |
| Stage1-vs-Stage4 |
7.718800E-03 |
| Stage2-vs-Stage3 |
9.547600E-01 |
| Stage2-vs-Stage4 |
1.249390E-01 |
| Stage3-vs-Stage4 |
1.398250E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.246400E-02 |
| Normal-vs-AfricanAmerican |
7.978000E-01 |
| Normal-vs-Asian |
2.291400E-01 |
| Caucasian-vs-AfricanAmerican |
7.787900E-02 |
| Caucasian-vs-Asian |
2.096200E-01 |
| AfricanAmerican-vs-Asian |
2.104000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.334400E-01 |
| Normal-vs-Female |
2.401800E-02 |
| Male-vs-Female |
5.688000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.204600E-01 |
| Normal-vs-Extreme_Weight |
3.814800E-01 |
| Normal-vs-Obese |
2.147800E-01 |
| Normal-vs-Extreme_Obese |
4.631000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.911600E-01 |
| Normal_Weight-vs-Obese |
5.211000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.201000E-01 |
| Extreme_Weight-vs-Obese |
6.514800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.005800E-01 |
| Obese-vs-Extreme_Obese |
5.560400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.134600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.457600E-02 |
| Normal-vs-Age(61-80Yrs) |
6.587000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.011800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.622400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.653380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.974800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.441800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.830010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.398200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.782200E-03 |
| Normal-VS-Type2 PRCC |
1.938390E-01 |
| Normal-VS-KIRP CIMP |
4.544600E-01 |
| Normal-VS-Unclassified PRCC |
1.343560E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.21870000002744E-06 |
| Type1 PRCC-VS-KIRP CIMP |
9.014100E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
7.052800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.057400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.019690E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.522500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.177600E-01 |
| Normal-vs-N1 |
8.865200E-01 |
| Normal-vs-N2 |
3.816000E-01 |
| N0-vs-N1 |
7.502000E-01 |
| N0-vs-N2 |
4.810000E-01 |
| N1-vs-N2 |
3.670400E-01 |
|
|
